Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy
Authors:
- 18 September 2019
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 72 (3) , 448-453
Abstract
Objective: In 2016, the American Academy of Ophthalmology (AAO) changed the recommended daily dose of hydroxychloroquine (HCQ) from 6.5 mg/kg to P < 0.0001), higher body mass index (P for trend = 0.0160), and longer duration of HCQ intake (P = 0.0024 and P for trend = 0.0006) were associated with a higher risk of HCQ toxicity. Higher blood levels of HCQ predicted later HCQ retinopathy (P = 0.0124 and P = 0.0340 for mean and maximum HCQ blood levels, respectively).Conclusion: Our data prove the utility of assessing blood levels of HCQ in the prediction of retinopathy. This would allow clinicians to either decrease the dose or increase monitoring in those patients with high HCQ blood levels.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR069572)
This publication has 39 references indexed in Scilit:
- Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody–Associated Cardiac Manifestations of Neonatal LupusCirculation, 2012
- Cutaneous lupus erythematosus: Update of therapeutic optionsJournal of the American Academy of Dermatology, 2011
- Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine RetinopathyOphthalmology, 2011
- Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquineAnnals of the Rheumatic Diseases, 2010
- Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic reviewAnnals of the Rheumatic Diseases, 2010
- Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)Annals of the Rheumatic Diseases, 2007
- Hydroxychloroquine concentration–response relationships in patients with rheumatoid arthritisArthritis & Rheumatism, 2002
- Analysis of the ABCR (ABCA4) gene in 4-aminoquinoline retinopathy: is retinal toxicity by chloroquine and hydroxychloroquine related to Stargardt disease?American Journal of Ophthalmology, 2001
- Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practiceArthritis & Rheumatism, 1997
- Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus?Arthritis & Rheumatism, 1987